3Riedel F, Gotte K, Bergler W, et al. Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck [J]. Oncol Rep, 2001,8(3): 471-476.
4West A F, O'Donnell M, Charlton R G, et al. Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer [J]. Br J Cancer, 2001,85 (4): 576-583.
5Yang E, Zha J, Jockel J, et al. Bad, a heterodimeric partner forbcl-xl and bcl-2, displace bax and promotes cell death[J]. Cell, 1995, 80 (2) :285-291.
6Oltvai ZN, Milliman CL, Korsmeyer SJ. bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death[J]. Cell, 1993, 74(4): 609-619.
7Nor JE, Christensen J, Liu J, et al. Up-Regulation of bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth [J]. Cancer Res, 2001,61 (5): 2183-2188.
8Pidgeon GP, Barr MP, Harmey JH, et al. Vascular endotheli al growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells [J]. Br J Cancer, 2001, 85(2): 273-278.Takehara T, Liu X, Fujimoto J, et al. Expression and role of bcl-xl in human hepatocellular carcinomas[J]. Hepatology, 2001, 34 (1): 55-61.
